14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
DEM vs DVYE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
DEM Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)
DEM Overall Winner
6-Pillar Tally: DEM 0 – 0 DVYE (6 Tie)
Matrix Metrics: DEM 2 – 1 DVYE
As of Nov 16, 2026, WisdomTree Emerging Markets High Dividend Fund (DEM) is the stronger overall head-to-head candidate over iShares Emerging Markets Dividend ETF (DVYE) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). DEM carries a Unified Composite Score of 60.4/100 (BUY) at $52.47 (N/M Forward P/E, N/A operating margin), whereas DVYE carries 68.1/100 (BUY) at $32.02 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While DVYE currently prints a higher short-term Unified Composite Score (68.1/100 BUY vs. DEM 60.4/100 BUY), DEM captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Technical & Structure Timing Caution: DEM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.2); meanwhile DVYE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DEM vs DVYE. Trailing 12-month operating profitability (DEM N/A vs DVYE N/A) and valuation multiples (DEM N/M vs DVYE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ DEM vs DVYE Key Questions & Quantitative Answers
As of Nov 16, 2026, WisdomTree Emerging Markets High Dividend Fund (DEM) is the stronger overall head-to-head candidate over iShares Emerging Markets Dividend ETF (DVYE) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). DEM carries a Unified Composite Score of 60.4/100 (BUY) at $52.47 (N/M Forward P/E, N/A operating margin), whereas DVYE carries 68.1/100 (BUY) at $32.02 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While DVYE currently prints a higher short-term Unified Composite Score (68.1/100 BUY vs. DEM 60.4/100 BUY), DEM captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: DEM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.2); meanwhile DVYE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
DEM and DVYE split Growth & Scale metrics: DEM posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with DVYE at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, DEM generates N/A in USD-normalized revenue versus N/A for DVYE. In operating R&D and SG&A reinvestment, DEM deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for DVYE.
DEM and DVYE trade at balanced relative valuation multiples. DEM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas DVYE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DEM (N/A ROE) versus DVYE (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, DEM carries 26.9% implied volatility (25th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.87β · 14% Vol realized risk). By comparison, DVYE carries 49.7% implied volatility (19th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.67β · 21% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.